Streptococcus agalactiae (Group B Streptococcus, GBS) normally colonizes healthy adults but can cause invasive disease, such as meningitis, in the newborn. To gain access to the central nervous system, GBS must interact with and penetrate brain or meningeal blood vessels; however, the exact mechanisms are still being elucidated. Here, we investigate the contribution of BspC, an antigen I/II family adhesin, to the pathogenesis of GBS meningitis. Disruption of the bspC gene reduced GBS adherence to human cerebral microvascular endothelial cells (hCMEC), while heterologous expression of BspC in non-adherent Lactococcus lactis conferred bacterial attachment. In a murine model of hematogenous meningitis, mice infected with ΔbspC mutants exhibited lower mortality as well as decreased brain bacterial counts and inflammatory infiltrate compared to mice infected with WT GBS strains. Further, BspC was both necessary and sufficient to induce neutrophil chemokine expression. We determined that BspC interacts with the host cytoskeleton component vimentin and confirmed this interaction using a bacterial two-hybrid assay, microscale thermophoresis, immunofluorescent staining, and imaging flow cytometry. Vimentin null mice were protected from WT GBS infection and also exhibited less inflammatory cytokine production in brain tissue. These results suggest that BspC and the vimentin interaction is critical for the pathogenesis of GBS meningitis. 
Introduction
Streptococcus agalactiae (Group B Streptococcus, GBS) is an opportunistic pathogen that asymptomatically colonizes the vaginal tract of up to 30% of healthy women. However, GBS possesses a variety of virulence factors and can cause severe disease when transmitted to susceptible hosts such as the newborn. Despite widespread intrapartum antibiotic administration to colonized mothers, GBS remains a leading cause of pneumonia, sepsis, and meningitis in neonates [1, 2] . Bacterial meningitis is a life-threatening infection of the central nervous system (CNS) and is marked by transit of the bacterium across endothelial barriers, such as the blood-brain barrier (BBB) or the meningeal blood-cerebral spinal fluid barrier (mBCSFB). Both consist of a single layer of specialized endothelial cells that serve to maintain brain homeostasis and generally prevent pathogen entry into the CNS [3] [4] [5] . Symptoms of bacterial meningitis may be due to the combined effect of bacterial adherence and brain penetration, direct cellular injury caused by bacterial cytotoxins, and/or activation of host inflammatory pathways that can disrupt brain barrier integrity and damage underlying nervous tissue. [6] [7] [8] Bacterial meningitis typically develops as a result of the pathogen spreading from the blood to the meninges. In order to disseminate from the blood into the brain, GBS must first interact with barrier endothelial cells [9] . A number of surface-associated factors that contribute to GBS-brain endothelium interactions have been described such as lipoteichoic acid (LTA) [10] , pili [11] , serine-rich repeat proteins (Srr) [12] , and streptococcal fibronectin-binding protein (SfbA) [13] . Pili, the Srr proteins, and SfbA have been shown to interact with extracellular matrix (ECM) components, which may help to bridge to host receptors such as integrins or other ECM receptors. However, a direct interaction between a GBS adhesin and an endothelial cell receptor has not been described.
Antigen I/II family (AgI/II) proteins are multifunctional adhesins that have been well characterized as colonization determinants of oral streptococci [14] . These proteins mediate attachment of Streptococcus mutans and Streptococcus gordonii to tooth surfaces and can stimulate an immune response from the colonized host [14] . Genes encoding AgI/II polypeptides are found in streptococcal species indigenous to the human mouth as well as other pathogenic 5DZA, respectively) [15] , and approximately two-thirds of the A-domain sequence was modeled on human fibrinogen (PDB entry 3GHG) [22] . It was not possible to generate models for the N-and P-domains, so the N-domain is shown as a sphere and the P-domain shown is a mirror image of the A-domain.
We performed precise in-frame allelic replacement to generate a ΔbspC mutant in GBS strain COH1, a hypervirulent GBS clinical isolate that is highly associated with meningitis (sequence type [ST]-17, serotype III) [23, 24] , using a method described previously [10] . We further determined the expression of surface BspC in the WT and complemented strains The GBS adhesin BspC interacts with vimentin to promote meningitis PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007848 June 10, 2019 compared to the ΔbspC mutant by flow cytometry and immunofluorescent staining with specific BspC antibodies (S1A-S1G Fig) . Growth curve analysis demonstrated that the ΔbspC mutant grew similarly to the WT parental strain under the conditions used here (S1H Fig). Similarly, we observed no differences in hemolytic activity or capsule abundance between the WT and mutant strains (S1I-S1L Fig) . High-magnification scanning electron microscopy (SEM) images of COH1 strains showed that the ΔbspC deletion strain exhibits similar surface morphology to the isogenic wild type (Fig 2A and 2B) . However, lower-magnification SEM revealed that the ΔbspC mutant appeared to exhibit decreased interaction between neighboring cells (Fig 2C and 2D) .
BspC promotes bacterial adherence to endothelial cells in vitro
Since AgI/II proteins are known to demonstrate adhesive properties in other streptococci [14] , we hypothesized that BspC would contribute to GBS interaction with brain endothelium. Thus, we characterized the ability of the ΔbspC mutant to attach to and invade hCMEC using our established adherence and invasion assays [10, 25] . The ΔbspC mutant exhibited a significant decrease in adherence to hCMEC compared to WT GBS, and this defect was complemented when BspC was expressed in the ΔbspC mutant strain (Fig 2E) . This resulted in less recovery of intracellular ΔbspC mutant (Fig 2F) , but together these results indicate that BspC contributes primarily to bacterial attachment to hCMEC. To determine if BspC was sufficient to confer adhesion, we heterologously expressed the GBS bspC gene in the non-adherent, nonpathogenic bacterium Lactococcus lactis. Flow cytometric analysis of L. lactis confirmed surface expression of BspC protein in the strain containing the pMSP.bspC plasmid (S2 Fig). BspC expression resulted in a significant increase in L. lactis adherence to hCMEC compared to L. lactis containing the control vector, while invasion was not affected (Fig 2G and 2H ). These results demonstrate that BspC is both necessary and sufficient to confer bacterial adherence to hCMEC.
BspC contributes to pathogenesis of GBS meningitis in vivo
Our results thus far suggest a primary role for BspC in GBS adherence to brain endothelium. We hypothesized that these in vitro phenotypes would translate into a diminished ability to penetrate the BBB and produce meningitis in vivo. Using our standard model of GBS hematogenous meningitis [10, 26, 27] , mice were challenged with either WT GBS or the ΔbspC mutant as described in the Methods. The WT GBS strain caused significantly higher mortality than the isogenic ΔbspC mutant strain (Fig 3A) . By 48 hours, 80% of mice infected with WT COH1 had succumbed to death, while all of the mice infected with the ΔbspC mutant survived up to or past the experimental endpoint. In a subsequent experiment mice were infected with a lower dose of either WT GBS or the ΔbspC mutant and were sacrificed at a defined endpoint (72 hrs) to determine bacterial loads in blood, lung, and brain tissue. We recovered similar numbers of the ΔbspC mutant strain from mouse blood and lung compared to WT; however, we observed a significant decrease in the amounts of the ΔbspC mutant recovered from the brain tissue (Fig 3B) . To confirm these results using other GBS strains, we constructed bspC gene deletions as described in the Methods in two other GBS strains: GBS 515 (ST-23, serotype Ia) and meningeal isolate 90356 (ST-17, serotype III). Mice infected with these mutant strains were also less susceptible to infection and exhibited decreased bacterial loads in the brain compared to the isogenic parental WT strains (S2 Fig) . Interestingly, the ΔbspC mutant in the 515 GBS background, which is a different sequence type and serotype from the other two strains, appeared to also exhibit diminished infiltration into the mouse lungs.
As excessive inflammation is associated with CNS injury during meningitis, we performed histological analysis of brains from infected animals. In WT infected mice, we observed leukocyte infiltration and meningeal thickening characteristic of meningitis that was absent in the mice infected with the ΔbspC mutant strain (Fig 3C and 3D) . Representative images from 8 mice, 4 infected with WT ( Fig 3C) and 4 infected with the ΔbspC mutant (Fig 3D) are shown where the major areas of inflammation were observed. In subsequent experiments to quantify the total inflammatory infiltrate, whole brains from uninfected mice and mice infected with either WT GBS or ΔbspC mutant GBS were processed and analyzed by flow cytometry as described in the Methods. There was no significant difference in the numbers of CD45 positive cells between the groups of mice, however within the CD11b positive population we observed higher numbers of Ly6C positive and Ly6G positive cells in the brains of animals infected with WT GBS compared to uninfected mice and mice infected with the ΔbspC mutant strain ( Fig  3E and 3F) , indicating an increased population of monocytes and neutrophils. Consistent with these results, we further observed that mice challenged with WT GBS had significantly more of the neutrophil chemokine, KC, as well as the proinflammatory cytokine, IL-1β, in brain homogenates than ΔbspC mutant infected animals. (Fig 3G and 3H) BspC is necessary and sufficient to induce neutrophil chemokine signaling
To further characterize the role of BspC in stimulating immune signaling pathways we infected hCMEC with WT GBS, the ΔbspC mutant, or the complemented strain. After four hours of infection, we collected cells and isolated RNA for RT-qPCR analysis to quantify IL-8 and CXCL-1 transcripts. We focused on the neutrophil chemokines IL-8 and CXCL-1 as these cytokines are highly induced during bacterial meningitis [28] and we observed an increase in neutrophilic infiltrate in brain tissue during the development of GBS meningitis in our mouse The GBS adhesin BspC interacts with vimentin to promote meningitis model. Cells infected with WT GBS had significant increases of both transcripts compared to cells infected with the ΔbspC mutant. Complementation of the bspC mutation restored the ability of the bacteria to stimulate the expression of IL-8 and CXCL-1 (Fig 4A and 4B) . Additionally, treatment of hCMEC with purified BspC protein resulted in increased transcript abundance (Fig 4C and 4D ) and protein secretion (Fig 4E and 4F) for both IL-8 and CXCL-1 compared to untreated cells or treatment with control protein, CshA from Streptococcus gordonii, that was similarly purified from E. coli. Nuclear factor-κB (NF-κB) represents a family of inducible transcription factors, which regulates a large array of genes involved in different processes of the immune and inflammatory responses, including IL-8, CXCL-1 and IL-1 [29] . To assess whether the NF-κB pathway is activated by BspC, we utilized the Hela-57A NF-κB luciferase reporter cell line as described previously [30] . Cells infected with WT GBS had significantly higher luciferase activity than uninfected and ΔbspC mutant GBS infected cells, indicating that BspC contributes to NF-κB activation (Fig 4G) . Additionally, immunofluorescent staining of hCMEC revealed an increase in p65 expression, an indicator of NF-κB activation, during infection with WT GBS but not in response to infection with ΔbspC mutant GBS (Fig 4H-4J ).
BspC interacts with the host endothelial cytoskeletal component vimentin
We next sought to identify the host protein receptor on brain endothelial cells that interacts with BspC. Membrane proteins of hCMEC were separated by 2-dimensional electrophoresis (2-DE), then blotted to a PVDF membrane. Following incubation with biotinylated BspC protein, the PVDF membrane was incubated with a streptavidin antibody conjugated to HRP. While many proteins were detected on the Coomassie stained gel, biotinylated BspC protein specifically interacted predominately with one spot in the PVDF membrane with molecular mass around 50-55 kDa and isoelectric point (pI) around 5 (Fig 5A and 5B) . The corresponding spot from the Coomassie-stained 2-DE gel was excised and digested with trypsin ( Fig 5C) . Resulting peptides were analyzed by liquid chromatography-tandem mass spectrometry. The spectra from the spot yielded 158 peptide sequences which matched to human vimentin. The molecular weight, 53.6 kDa, and calculated pI, 5.12, of vimentin match the values for the spot on the 2-DE gels. This procedure was repeated for membrane proteins from another human brain endothelial cell line (hBMEC) that has been used previously to study GBS interactions [31] . Mass spectrometry analysis also determined that BspC interacted with human vimentin (S3A-S3C). The control far Western blot with the streptavidin antibody conjugated to HRP did not show any hybridization (S3D Fig) .
To confirm these protein-protein interactions in vivo, we employed a bacterial two-hybrid system (BACTH, "Bacterial Adenylate Cyclase-Based Two-Hybrid") [32] . This system is based on the interaction-mediated reconstitution of a cyclic adenosine monophosphate (cAMP) signaling cascade in Escherichia coli, and has been used successfully to detect and analyze the interactions between a number of different proteins from both prokaryotes and eukaryotes [33] . Using a commercially available kit (Euromedex) according to manufacturer's directions and as described previously [34] , vimentin was cloned and fused to the T25 fragment as a Nterminal fusion (T25-Vimentin), using the pKT25 plasmid, and bspC was cloned as a C-terminal fusion (BspC-T18) using the pUT18 plasmid. To test for interaction, these plasmids were transformed into an E. coli strain lacking adenylate cyclase (cyaA). We observed blue colonies The GBS adhesin BspC interacts with vimentin to promote meningitis when grown on LB agar plates containing X-gal, indicating β-galactosidase activity and a positive interaction between Vimentin and BspC compared to the empty vector control (Fig 5D  and 5E ). A leucine zipper that is fused to the T25 and T18 fragments served as the positive control for the system (Fig 5F) . To quantify β-galactosidase activity, cells grown to log phase were permeabilized with 0.1% SDS and toluene and enzymatic activity measured by adding ONPG as described previously [34] . The E. coli strain containing both vimentin and BspC expressing plasmids exhibited increased β-galactosidase activity (Miller units) compared to the empty vector control strain (Fig 5G) . We also quantified the interaction between BspC and vimentin by performing microscale thermophoresis (MST) [35] as described in Methods. The dissociation constant (K d ) was 3.39μM as calculated from the fitted curve that plots normalized fluorescence against concentration of vimentin (S4E Fig) . These results demonstrate a direct interaction between BspC and vimentin.
GBS co-localization with cell-surface vimentin is dependent on BspC
To visualize the localization of WT GBS and vimentin in brain endothelial cells we performed imaging flow cytometry of uninfected and WT GBS infected hCMEC. Cells were fixed, permeabilized, and incubated with antibodies to vimentin and GBS. We observed that vimentin protein was present throughout the cytoplasm of uninfected hCMEC (Fig 6A and 6B ), but during infection GBS co-localized with vimentin near the surface of infected cells (Fig 6C and 6D ). To further characterize the localization of GBS and vimentin, we performed immunofluorescent staining of hCMEC infected with either WT GBS or the ΔbspC mutant. Following infection, cells were fixed but not permeabilized to permit labeling of only extracellular bacteria and surface expressed vimentin. We observed that surface vimentin of hCMEC co-localized with WT GBS bacteria, while this was not seen for hCMEC infected with the ΔbspC mutant (Fig 6E-6H ).
To quantify co-localization of GBS with vimentin, the number of bacteria that overlapped with the vimentin signal was divided by the total number of bacteria in each field of view (Fig 6I) . No staining of either GBS or vimentin was observed in IgG controls (Fig 6J-6L ).
BspC and vimentin promote GBS attachment to cells in vitro
To first determine if BspC-mediated attachment to cells is dependent on vimentin, we infected HEK293T cells with lentiviruses containing either the vimentin expression plasmid pLenti-VIM or the vector control pLenti-mock. Immunofluorescent staining reveals that HEK293T pLenti-mock cells do not express vimentin while the HEK203T pLenti-VIM clone exhibits strong vimentin labelling ( Fig 7A and 7B) . WT GBS was significantly more adherent to HEK293T cells that express vimentin while the ΔbspC mutant showed no difference in attachment to either cell line ( Fig 7C) . Next, we assessed the effect of blocking the vimentin-GBS interaction by treating hCMEC with anti-vimentin antibodies prior to infection with GBS ( Fig  7D) . Treatment with a vimentin antibody that recognizes the N-terminal epitope (AA31-80), as well as with IgG isotype controls did not alter adherence of the WT or ΔbspC mutant strains; however, pre-incubation with the mouse V9 antibody [36, 37] , which reacts with the C-terminal of vimentin (AA405-466), reduced WT GBS adherence to levels comparable to the adherence of the ΔbspC mutant (Fig 7E and 7F) . These results indicate that the interaction between BspC and cell-surface vimentin is dependent on the C-terminus of vimentin.
Vimentin contributes to the pathogenesis of meningitis in vivo
We obtained WT 129 and 129 vimentin KO mice and confirmed the absence of vimentin in the brain endothelium of the KO animals by immunofluorescent staining (S5A and S5B Fig) .
To determine the necessity of vimentin in GBS meningitis disease progression, we infected WT and vimentin KO mice with WT GBS and observed that they were less susceptible to GBS infection and exhibited increased survival compared to WT animals ( Fig 8A) . Further, significantly less bacteria were recovered from the tissues of KO mice compared to the tissues of WT mice (Fig 8B) . WT and vimentin KO mice infected with ΔbspC mutant GBS showed no difference in survival and tissue bacterial counts (S6 Fig). Additionally, for animals infected with WT GBS, we detected significantly less KC and IL-1β in brain tissues of vimentin KO compared to WT mice, suggesting that vimentin contributes to the initiation of immune signaling pathways during GBS infection (Fig 8C and 8D ). Taken together these results indicate the importance of vimentin in GBS dissemination into the brain and meningitis disease progression.
Discussion
Our studies reveal a unique requirement for the Group B streptococcal antigen I/II protein, BspC, to brain penetration by GBS, the leading agent of neonatal bacterial meningitis. A decreased ability by the GBS ΔbspC mutant to attach to brain endothelium and induce neutrophil chemoattractants in vitro was correlated with a reduced risk for development of meningitis and markedly diminished lethality in vivo. We identified that BspC interacts directly with host vimentin and that blocking this interaction abrogated BspC-mediated attachment to hCMEC. Further, vimentin deficient mice infected with GBS exhibited decreased mortality, bacterial brain loads, and cytokine production in brain tissue. These results corroborate the growing evidence that this intermediate filament protein plays important roles in the pathogenesis of bacterial infections [38] , and provide new evidence for the pivotal role of the BspC adhesin in GBS CNS disease (Fig 9) . The oral streptococcal AgI/II adhesins range in composition from 1310-1653 amino acid (AA) residues, while GBS AgI/II proteins are smaller (826-932 AA residues) [39] . The primary sequences of AgI/II proteins are comprised of six distinct regions (Fig 1B) , several of which have been shown to mediate the interaction to various host substrates. The S. mutans protein SpaP as well as the S. gordonii proteins SspA and SspB have been demonstrated to interact specifically with the innate immunity scavenger protein gp-340. [40] Recently, the GAS AgI/II protein AspA, as well as BspA, the AgI/II homolog expressed mainly by the GBS strain NEM316, have also been shown to bind to immobilized gp-340 [15, 18] . Gp-340 proteins are involved in various host innate defenses and are present in mucosal secretions, including saliva in the oral cavity and bronchial alveolar fluid in the lung. They can form complexes with other mucosal components such as mucins and function to trap microbes for clearance. However, when gp-340 is immobilized, it can be used by bacteria as a receptor for adherence to the host surface. [15, [41] [42] [43] [44] . There is evidence that the Variable (V) regions of SspB, SpaP, AspA and BspA facilitate gp340-binding activity [15, [45] [46] [47] . AgI/II family adhesins have also been shown to interact with other host factors including fibronectin, collagen, and β1 integrins to promote host colonization [14, [48] [49] [50] , demonstrating the multifactorial nature of these adhesins. It is unknown if GBS BspC interactions with other host factors are similar to those of the The GBS adhesin BspC interacts with vimentin to promote meningitis The GBS adhesin BspC interacts with vimentin to promote meningitis [52] . However, vimentin is also found on the surface of numerous cells such as T cells, platelets, neutrophils, activated macrophages, vascular endothelial cells, skeletal muscle cells, and brain microvascular endothelial cells [53] [54] [55] [56] [57] [58] [59] [60] . Vimentin also mediates a variety of cellular processes including cell adhesion, immune signaling, and autophagy [55, 61, 62] . Further, the role of cell surface vimentin as an attachment receptor facilitating bacterial or viral entry has been previously documented for other pathogens [38, [63] [64] [65] . The BspC domain that mediates the vimentin interaction is currently under investigation. As the V domain is likely projected from the cell surface and has been implicated in host interactions for other streptococci, we hypothesize that this may be a critical domain for this interaction. Additionally, as the V-domain of other Bsp homologs share 96-100% identity with the V-domain of BspC, we predict that the other Bsp proteins might also interact with vimentin, but this would be a topic for future investigation.
There is a growing body of evidence that various bacteria can interact with vimentin to promote their pathogenesis, including Escherichia coli K1, Salmonella enterica, Streptococcus pyogenes, and Listeria monocytogenes. Thus, vimentin has been shown to be important in experimental models of infection at body sites other than the brain [38, 57, 60, 66, 67] . Interestingly, previous studies on the meningeal pathogen E. coli K1 have demonstrated that the bacterial surface factor, IbeA, interacts with vimentin to promote bacterial uptake into brain endothelial cells [60, 68] . Similarly, while our study was underway, it was reported that another bacterium capable of causing meningitis, L. monocytogenes, uses InlF to interact with vimentin to promote brain invasion [67] . Along with our results presented here, this may suggest a common mechanism for meningeal bacterial pathogens to penetrate the BBB and cause CNS disease. However, our analysis of these three bacteria proteins showed no homology or predicted regions that might commonly interact with vimentin. Furthermore, the interaction between the E. coli receptor IbeA and the L. monocytogenes receptor InlF with cell-surface vimentin can be blocked by an antibody to the N-terminal region of vimentin [60, 67 ], while we demonstrate that the interaction between BspC and cell-surface vimentin can be blocked with an antibody to the C-terminal of vimentin. The implications of this unique interaction between a bacterial receptor and the C-terminal of vimentin remain to be explored.
Neuronal injury during bacterial meningitis involves both microbial and host factors, and subsequent to attachment to the brain endothelium and penetration of the BBB, GBS stimulation of host immune pathways is the next important step in the progression of meningitis. The release of inflammatory factors by brain endothelial cells, microglia, astrocytes, and infiltrating immune cells can exacerbate neuronal injury [9] . Our data suggest that, like other streptococcal AgI/II family polypeptides, BspC plays a role in immune stimulation. AgI/II family proteins contain two antigenic regions (the antigens I/II and II) [69] and this ability to elicit an inflammatory response makes SpaP, the S. mutans AgI/II protein, an attractive candidate for vaccine development to prevent dental caries [14, 70] . In this study we found that BspC can stimulate NF-κB activation and the release of the proinflammatory cytokines IL-8 and CXCL-1 from hCMEC. Both of these chemokines are major neutrophil recruiting chemoattractants and are the most highly induced during GBS infection [27, 71] . We observed that mice infected with GBS mutants that lack BspC exhibited lower brain bacterial loads and less meningeal inflammation compared to animals challenged with WT GBS. Interestingly, WT and ΔbspC mutant bacterial loads were similar in the blood, indicating that BspC may not influence GBS survival and proliferation in the blood; however, further investigation is warranted.
This study demonstrates for the first time the importance of a streptococcal AgI/II protein, BspC, in the progression of bacterial meningitis. Our data demonstrate that BspC, likely in concert with other GBS surface determinants mentioned above (pili, Srr1/2, SfbA), contributes to the critical first step of GBS attachment to brain endothelium. As the other described GBS surface factors have been shown to interact with ECM components, BspC may mediate a more direct interaction with the host cell as it facilitates interaction with vimentin. We have observed a unique requirement for vimentin to the pathogenesis of CNS disease; vimentin KO mice were markedly less susceptible to GBS infection and exhibited reduced bacterial tissue load and inflammatory signaling. Vimentin is also known to act as a scaffold for important signaling molecules and mediates the activation of a variety of signaling pathways including NOD2 (nucleotide-binding oligomerization domain-containing protein 2) and NLRP3 (nucleotide-binding domain, leucine-rich-containing family pyrin domain-containing-3) that recognize bacterial peptidoglycan and activate inflammatory response via NF-κB signaling [68, 72, 73] . Thus, continued investigation into the mechanisms of how BspC-vimentin interactions dually promote bacterial attachment and immune responses, as well as how BspC expression may be regulated and whether known GBS two-component systems are involved, is warranted. These studies will provide important information that may inform future therapeutic strategies to limit GBS disease progression.
Materials and methods

Ethics statement
Animal experiments were approved by the committee on the use and care of animals at San Diego State University (SDSU) protocol #16-10-021D and at University of Colorado School of Medicine protocol #00316 and performed using accepted veterinary standards. San Diego State University and the University of Colorado School of Medicine are AAALAC accredited; and the facilities meet and adhere to the standards in the "Guide for the Care and Use of Laboratory Animals."
Bacterial strains, growth conditions, proteins, and antibodies
GBS clinical isolate COH1 (serotype III) [74] , 515 (serotype Ia) [20] , the recent meningitis isolate 90356 (serotype III) [75] and their isogenic ΔbspC mutants were used for the experiments. GBS strains were grown in THB (Hardy Diagnostics) at 37˚C, and growth was monitored by measuring the optical density at 600 nm (OD 600 ). Lactococcus lactis strains were grown in M17 medium (BD Biosciences) supplemented with 0.5% glucose at 30˚C. For antibiotic selection, 2 μg/mL chloramphenicol (Sigma) and 5 μg/mL erythromycin (Sigma) were incorporated into the growth medium. BspC and CshA recombinant proteins, and the BspC antibody were purified as described previously [15, 76] . The anti-BspC polyclonal antibody was further adsorbed (as described in [77] ) against COH1ΔbspC bacteria to remove natural rabbit antibodies that react with bacterial surface antigens. Briefly, anti-BspC antibody was diluted to 2.28 mg/mL in PBS and incubated with COH1ΔbspC bacteria overnight at 4˚C, with rotation. Bacteria were pelleted by centrifugation and the supernatant was collected and filtered using 0.22 μM cellulose acetate SpinX centrifuge tube filters (Costar). A normal rabbit IgG antibody (Invitrogen) was adsorbed as described above, and utilized as a negative isotype control.
Targeted mutagenesis and complementation vector construction
The ΔbspC mutant was generated in COH1 and 90356 by in-frame allelic replacement with a chloramphenicol resistance cassette by homologous recombination using a method previously described [10] . A knockout construct was generated by amplifying up-and down-flanking regions of the bspC gene from COH1 genomic DNA using primer pairs of 5'flank-F (GCAGA CACCGATTGCACAAGC)/R (GAAGGCGATCTTGCCCTCAA) and 3'flank-F (GTCAGC TATCGGTTTAGCAGG)/R(CTATACACGCCTACAGGTGTC). The chloramphenicol resistance (cat) cassette was amplified with primers Cat-F (GAGGGCAAGATCGCCTTCATGGA GAAAAAAATCACTGGAT) and Cat-R (CTGCTAAACCGATAGCTGACTTACGCCCC GCCCTGCCACT). Then the construct of two flanks along with the cat cassette was amplified with a pair of nest primers, Nest-xhoI (CCFCTCGAGGATGCTCAAGATGCACTCAC) and Nest-xbaI (GCTCTAGACGAGCCAAATTACCCCTCCT), which was then cloned into the pHY304 vector [78] and propagated in E. coli strain DH5α [79] prior to isolation and transformation to COH1 and 90356 GBS. A ΔbspC mutant had been generated previously in 515 [20] . The complemented strain of ΔbspC mutant in COH1 was generated by cloning bspC into pDCerm, an E. coli-GBS shuttle expression vector. Gene bspC was amplified from GBS 515 genomic DNA using primers pDC.bspC.F (TGGGTACCAGGAGAAAATATGTATAAAAAT CAAAC) and pDC.bspC.R (CCGGGAGCTCGCAGGTCCAGCTTCAAATC), designed to encode a KpnI and SacI restriction site at its termini respectively. This bspC amplicon was then cloned into pDCerm and propagated in E. coli strain Stellar (ClonTech), prior to isolation and transformation into COH1 GBS. A L. lactis strain expressing BspC had been generated previously [20] .
Hemolysis assay
GBS strains were grown to an OD 600 of 0.4, harvested by centrifugation, and resuspended in PBS. A total of 1 x 10 8 CFU was added to fresh sheep blood (VWR) in V-bottom 96-well plates (Corning). The plates were sealed and incubated at 37˚C with agitation for 1 h. The plates were centrifuged at 200 x g for 10 min, and 100 μl of the supernatant was transferred to a flatbottom 96-well plate. The absorbance at 541nm (A 541 ) was read, and percent hemolysis was calculated by comparing the A 541 values for GBS-treated wells to the A 541 values for the wells with blood incubated with water.
GBS BspC and capsule flow cytometry
Flow cytometry to determine BspC and capsule expression was performed as described in [80] . Briefly, bacterial stocks were washed in sterile PBS containing 0.5% bovine serum albumin (BSA) (VWR) then incubated with a purified monoclonal anti-serotype III antibody or a purified monoclonal anti-serotype Ia isotype control at a 1:10,000 dilution, washed via centrifugation, and labeled with a donkey anti-mouse IgM conjugated to AlexaFluor647 (Invitrogen) at a 1:2,000 dilution. All incubations were performed at 4˚C with shaking. Samples were washed again then resuspended and read on a FACScalibur flow cytometer (BD Biosciences), and analyzed using FlowJo (v10) software. The monoclonal antibodies were provided by John Kearney at the University of Alabama at Birmingham.
To stain for surface BspC expression, GBS were grown to OD 600 of 0.25 in EndoGRO-MV culture medium (Millipore) in order to mimic host infection conditions, pelleted by centrifugation, resuspended in PBS and frozen L. lactis strain stocks were thawed and washed in buffer. Approximately, 1 x 10 6 CFU of each strain was incubated with either adsorbed antiBspC antibody or adsorbed anti-rabbit IgG at a 1:50 dilution at 4˚C, overnight, with rotation. The next day, bacteria were washed via centrifugation, and labeled with a donkey anti-rabbit IgG conjugated to AlexaFluor488 (Invitrogen) at a 1:2,000 dilution for 45 minutes at room temperature with rotation. Samples were washed again then resuspended and read on a FACScalibur flow cytometer (BD Biosciences), and analyzed using FlowJo (v10) software.
Immunofluorescent staining of GBS
Bacteria were grown to an OD 600 of 0.25 in EndoGRO-MV culture medium (Millipore), the bacteria suspension was smeared on charged glass slides (Fisher), and the slides were fixed with 4% paraformaldehyde for 30 min at room temperature. The slides were blocked with 3% BSA for 1 hour, then incubated with rabbit antibodies to BspC or IgG at a 1:50 dilution followed by donkey anti-rabbit conjugated to AlexaFluor488 (Invitrogen). Bacteria were imaged using a BZ-X710 fluorescent microscope (Keyence).
Scanning electron microscopy
Bacteria were grown to log phase and were then fixed for 10 min using a one-step method with 2.5% glutaraldehyde, 1% osmium tetraoxide, 0.1M sodium cacodylate. Bacteria were collected on 0.4 μM polycarbonate filters by passing the solution through a swinnex device outfitted on a 10 mL syringe. The filters were dehydrated through a series of increasing ethanol concentrations and then dried in a Tousimis SAMRI-790 critical point drying machine. The dried filters were mounted on SEM sample stubs with double-sided carbon tape, coated with 6nm platinum using a Quorom Q150ts high-resolution coater and imaged with a FEI FEG450 scanning electron microscope.
Cell lines and infection assays
Cells of the well-characterized human cerebral microvascular endothelial cell line (hCMEC/ D3), referred to here as hCMEC were obtained from Millipore and were maintained in an EndoGRO-MV complete medium kit supplemented with 1 ng/ml fibroblast growth factor-2 (FGF-2; Millipore) [81] [82] [83] [84] . Hela57A were provided by Marijke Keestra-Gounder at the University of Colorado, Anschutz Medical Campus and cultured in DMEM (Corning Cellgro) containing 10% fetal bovine serum (Atlanta Biologicals). HEK293T cells were obtained from Origene and cultured in DMEM containing 10% fetal bovine serum and 2mM L-glutamine (Thermo Fisher). The lentiviral expression plasmid pLenti-C-Myc-DDK harboring the human vimentin gene (NM_003380, pLenti-VIM) was obtained from Origene. To generate lentiviruses, HEK293T cells were transfected with the pLenti-VIM plasmid in combinations with the packaging plasmid psPAX2 and the envelope plasmid pMD2.G (Addgene) using TransIT_293 transfection reagent (Mirus). After an 18 h incubation, the culture supernatant containing lentiviruses was harvested and filtered through a 0.45 μm syringe filter to remove cellular debris. The viral titer was 10 6 to 10 7 transduction units (TU) per mL. 10 5 fresh HEK293T cells were infected with lentiviruses at a MOI of 5 for 24 h in the presence of 10 μg/mL polybrene (Sigma). The empty lentiviral expression plasmid pLenti-mock was used as a vector control. Assays to determine the total number of cell surface-adherent or intracellular bacteria were performed as describe previously [10] . Briefly, bacteria were grown to mid-log phase to infect cell monolayers (1 × 10 5 CFU, at a multiplicity of infection [MOI] of 1). Total cell-associated GBS and L. lactis were recovered following a 30 min incubation, while intracellular GBS were recovered after 2 h infection and 2 h incubation with 100 μg gentamicin (Sigma) and 5 μg penicillin (Sigma) to kill all extracellular bacteria. Cells were detached with 0.1 ml of 0.25% trypsin-EDTA solution and lysed with addition of 0.4 ml of 0.025% Triton X-100 by vigorous pipetting. The lysates were then serially diluted and plated on THB agar to enumerate bacterial CFU. For antibody pre-treatment assays, hCMEC were incubated with 0.3 μg/ml antibodies for 30 min prior to infection with GBS. The mouse monoclonal antibody to vimentin, clone V9 (Abcam), the rabbit polyclonal antibody to N-terminal vimentin (Sigma), and the isotype controls (VWR) were used. Total cell-associated GBS were recovered following a 1h incubation. For luciferase assays, Hela57A cells were infected with 1 x 10 6 CFU (MOI, 10) GBS for 90 min. Cells were then lysed and luciferase activity quantified using a luciferase assay system (Promega) according to manufacturer's instructions.
Mouse model of hematogenous GBS meningitis
We utilized a mouse GBS infection model as described previously [10, 26, 27] . Briefly, 8-week old male CD-1 mice (Charles River), 129S WT, or 129S-Vim tm1Cba /MesDmarkJ (Vimentin KO) (Jackson Laboratory) were injected intravenously with 1 × 10 9 CFU of wild-type GBS or the isogenic ΔbspC mutant for a high dose challenge, or 1 × 10 8 CFU for a low dose challenge.
At the experimental endpoint mice were euthanized and blood, lung, and brain tissue were collected. The tissue was homogenized, and the brain homogenates and lung homogenates as well as blood were plated on THB agar for enumeration of bacterial CFU.
Histology
Mouse brain tissue was frozen in OCT compound (Sakura) and sectioned using a CM1950 cryostat (Leica). Sections were stained using hematoxylin and eosin (Sigma) and images were taken using a BZ-X710 microscope (Keyence).
Brain flow cytometry
At 48 h post-infection with 1 × 10 8 CFU of GBS, mice were euthanized then perfused to replace blood with PBS. The entire mouse brain was harvested from each animal and the tissue was processed with the Multi-Tissue Dissociation kit #1 following the Adult brain dissociation protocol (Miltenyi Biotec). Cells were resuspended in MACS buffer (Miltenyi Biotec) and incubated with antibodies to Ly6C conjugated to BV421, CD45 conjugated to PE, CD11b conjugated to FITC, and Ly6G conjugated to APC (Invitrogen) at 1:200 dilution, UltraLeaf antimouse CD16/CD32 Fc block (Biolegend) at 1:400 dilution, and fixable viability dye conjugated to eFLuor506 (eBioscience) at 1:1000 dilution for 1 h, then fixed (eBioscience). Cells were counted using a Countess automated cell counter (Invitrogen), read on a Fortessa X-20 flow cytometer (BD Biosciences), and analyzed using FlowJo (v10) software. Gates were drawn according to fluorescence minus one (FMO) controls.
RT-qPCR and ELISA
GBS were grown to mid-log phase and 1 × 10 6 CFU (MOI, 10) were added to hCMEC monolayers and incubated at 37˚C with 5% CO 2 for 4 h. Cell supernatants were collected, the cells were then lysed, total RNA was extracted (Machery-Nagel), and cDNA was synthesized (Quanta Biosciences) according to the manufacturers' instructions. Primers and primer efficiencies for IL-8, CXCL-1, and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) were utilized as previously described [85] . IL-8 and CXCL-1 from hCMEC supernatants, and KC and IL-1β from mouse brain homogenates were detected by enzyme-linked immunosorbent assay according to the manufacturer's instructions (R&D systems). and GBS (Genetex) at a 1:200 dilution overnight at 4˚C. Following washes with PBS and an incubation with donkey anti-mouse conjugated to Cy3 and donkey anti-rabbit conjugated to 488 secondary antibodies (ThermoFisher) at a 1:500 dilution for 1 h at room temperature, coverslips were washed with PBS and mounted onto glass microscopy slides (Fisher) with VEC-TASHIELD mounting medium containing DAPI (Vector Labs). Cells were imaged using a BZ-X710 fluorescent microscope (Keyence). Quantification of GBS and vimentin co-localization was performed by counting the number of GBS that co-localized with vimentin and dividing by the total number of GBS in each field. For Fig 7, HEK293T cells were incubated with the antibody to vimentin followed by a FITC-conjugated secondary antibody. Cells were imaged using a Cytation 5 fluorescent microplate reader (BioTek).
Immunofluorescent staining of hCMEC and HEK293T cells
2-dimensional electrophoresis (2-DE), far western blot, and mass spectrometry analysis
Membrane proteins of hCMEC cells were enriched using a FOCUS membrane protein kit (G Biosciences, St. Louis, MO), dissolved in rehydration buffer (7M urea, 2M thiolurea, 1% TBP, and 0.2% ampholytes 3-10 NL), and quantified using 2D Quant kit (GE Healthcare, Piscataway, NJ). Proteins (100μg) were loaded on 7-cm long immobilized pH gradient (IPG) strips with non-linear (NL) 3-10 pH gradient (GE Healthcare). Isoelectric focusing was carried out in Multiphor II electrophoresis system (GE Healthcare) in three running phases (phase 1: 250V/0.01h, phase 2: 3500V/1.5h, and phase 3: 3500V/ 4.5h). The second dimension SDS-PAGE was carried out using 12.5% acrylamide gels in duplicate. One gel was stained with Coomassie Blue G250 (Bio-Rad, Hercules, CA) for mass spectrometry analysis. The other gel was transferred to a PVDF membrane for far Western blot analysis. The PVDF membrane was denaturated and renaturated as described in [86] , followed by incubation in a blocking solution (5% skim milk in PBS) for 1 h. Recombinant BspC was biotinylated using a EZ-Link Sulfo-NHS-Biotin kit (ThermoFisher Scientific, Waltham, MA). The PVDF membrane was probed with the biotinylated BspC (100μg) in a blocking solution overnight at 4˚C. After washing three times with a washing buffer (PBS, 0.05% Tween-20), the PVDF membrane was incubated with an antibody conjugated to streptavidin-horse radish peroxidase (HRP). Interacting proteins were detected by adding enhanced chemiluminescence (ECL) reagents (ThermoFisher Scientific) and visualized by x-ray film exposure. The protein spots from far Western blot were aligned to the corresponding protein spots in the Coomassie stained gel. The identified spots were excised and digested in gel with trypsin (Worthington, Lakewood, NJ). Peptide mass spectra were collected on MALDI-TOF/TOF, (ABI 4700, AB Systems, Foster City, CA) and protein identification was performed using the automated result dependent analysis (RDA) of ABI GPS Explorer softwareV3.5. Spectra were analyzed by the Mascot search engine using the Swiss protein database.
Bacterial two-hybrid assay
A bacterial adenylate cyclase two-hybrid assay was performed as in [32] and following manufacturer's instructions (Euromedex). Briefly, plasmids containing T25-Vimentin and BspC-T18 were transformed into E. coli lacking cyaA and E. coli were plated on LB plates containing X-gal (Sigma). To measure β -galactosidase activity, Miller assays were performed according to standard protocols [87] . Briefly, E. coli were grown in 0.5mM IPTG (Sigma), then permeabilized with 0.1% SDS (Sigma) and toluene (Sigma). ONPG (Research Products International) was added and absorbance was measured at 600, 550, and 420nm.
Microscale thermophoresis
Three independent MST experiments were performed with His-tagged BspC labelled using the Monolith His-Tag Labeling Kit RED-tris-NTA 2 nd Generation (NanoTemper Technologies) according to manufacturer's instructions. The concentration of labelled BspC was kept constant at 10nM. Vimentin was purchased from Novus Biologicals and titrated in 1:1 dilutions to obtain a series of 16 titrations ranging in concentration from 20 μM to 0 μM. Measurements were performed in standard capillaries with a Monolith NT.115 Pico system at 20% excitation power and 40% MST power (NanoTemper Technologies).
Imaging flow cytometry
Following a 1 h infection with GBS, hCMEC were washed with PBS to remove non-adherent GBS. Cells were collected using a cell scraper (VWR) and resuspended in PBS containing 10% FBS and 1% sodium azide (Sigma). Cells were incubated with primary antibodies to vimentin (Abcam) and GBS (Genetex) at 1:500 dilution for 1 h at 4˚C followed by donkey anti-mouse conjugated to Cy3 and donkey anti-rabbit conjugated to 488 (ThermoFisher) secondary antibodies. Cells were then fixed (eBioscience) and analyzed using an ImageStream X imaging flow cytometer (Amnis).
Data analysis
GraphPad Prism version 7.0 was used for statistical analysis and statistical significance was accepted at P values of <0.05. ( � , P < 0.05; �� , P < 0.005; ��� , P < 0.0005; ���� , P < 0.00005). Specific tests are indicated in figure legends. 
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